India's Hetero wins approval to sell COVID-19 drug favipiravir

India's Hetero Labs Ltd has received regulatory approval to sell its version of anti-viral drug favipiravir to treat COVID-19, the drugmaker said on Wednesday, as coronavirus infections in the world's third worst-hit nation crossed 1.5 million.

from bdnews24.com - Home https://ift.tt/2P7jToV